Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer.
Oncotarget
; 12(21): 2232-2233, 2021 Oct 12.
Article
in En
| MEDLINE
| ID: mdl-34676057
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Prognostic_studies
/
Risk_factors_studies
Language:
En
Journal:
Oncotarget
Year:
2021
Document type:
Article
Affiliation country:
Japan
Country of publication:
United States